rewirebio.iobenchmarks
Dataset

NA12892/NA12891 virtual tumor and matched normal

NA12892/NA12891 virtual tumor and matched normal; bounded primary-source AMP candidate.

Research readiness

These checks assess whether the evidence supports a reproducible investigation. A source-checked score alone does not meet these requirements.

Release 2026-10-07-1448159e6a81 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • metric replay: verification is missing

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • metric replay: verification is missing
  • annotations: verification is missing
  • dependence: verification is missing

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • recipe pinned: verification is missing
  • resource estimate: verification is missing

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • artifact hashes: verification is missing
  • join integrity: verification is missing
  • score semantics: verification is missing
  • independent validation: verification is missing
  • overlap checked: verification is missing

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Read reviewed discrepancy investigations

Evaluation results

2 evaluations · 24 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.81 indel F1-score
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
1360 indel false negatives
variants · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
305 indel false positives
variants · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.92 indel precision
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.72 indel recall
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
3590 indel true positives
variants · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Lancet row (JATS Tab1)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.85 SNV F1-score
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
7740 SNV false negatives
variants · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
565 SNV false positives
variants · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.98 SNV precision
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.75 SNV recall
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: LancetProtocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
23,848 SNV true positives
variants · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Lancet evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Lancet row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.77 indel F1-score
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
1300 indel false negatives
variants · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
867 indel false positives
variants · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.81 indel precision
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.73 indel recall
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
3650 indel true positives
variants · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 1, Strelka2 row (JATS Tab1)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.85 SNV F1-score
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
7460 SNV false negatives
variants · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
1120 SNV false positives
variants · lower

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.96 SNV precision
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
0.76 SNV recall
fraction · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)
Configuration: Strelka2Protocol: Lancet paper virtual-tumor SNV/indel benchmark
Dataset: NA12892/NA12891 virtual tumor and matched normal
24,132 SNV true positives
variants · higher

Uncertainty: Not reported

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Strelka2 evaluation

Separate SNV and indel virtual-tumor pairs; real germline-supporting reads swapped at reference-homozygous/alternate-homozygous loci; binomial VAF means 0.05, 0.1, 0.2, 0.3; insertion max 13 bp, deletion max 35 bp.

Aggregation: Not reported

Genome-wide somatic variant calling using localized colored de Bruijn graphs · Table 2, Strelka2 row (JATS Tab2)

Source checking is not independent reproduction. Release 2026-10-07-1448159e6a81.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

7 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-07-1448159e6a81
Property and statementOriginal source and locationReview and provenance
attributes.accession
Not reported
Context-only references
Genome-wide somatic variant calling using localized colored de Bruijn graphs

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00
Retrieved: 2026-10-07T12:24:27.822425+00:00

missing or unspecified

No individual claim review recorded

Audit details

Field: attributes.accession

Source artifact SHA-256: 08fa271d01e0583f570c97dd0d260073caf8f48877fa9f6d6eabc858b6e518d5

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.assay
Illumina HiSeq X PCR-free WGS, 80× virtual tumor and 40× normal
Context-only references
Genome-wide somatic variant calling using localized colored de Bruijn graphs

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00
Retrieved: 2026-10-07T12:24:27.822425+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 08fa271d01e0583f570c97dd0d260073caf8f48877fa9f6d6eabc858b6e518d5

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.population
31,592 spiked SNVs; 4,945 spiked indels; NA12892 and NA12891 HapMap samples
Context-only references
Genome-wide somatic variant calling using localized colored de Bruijn graphs

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00
Retrieved: 2026-10-07T12:24:27.822425+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 08fa271d01e0583f570c97dd0d260073caf8f48877fa9f6d6eabc858b6e518d5

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.split
constructed evaluation; no training/test split extracted
Context-only references
Genome-wide somatic variant calling using localized colored de Bruijn graphs

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00
Retrieved: 2026-10-07T12:24:27.822425+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.split

Source artifact SHA-256: 08fa271d01e0583f570c97dd0d260073caf8f48877fa9f6d6eabc858b6e518d5

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

attributes.version
Not reported
Context-only references
Genome-wide somatic variant calling using localized colored de Bruijn graphs

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00
Retrieved: 2026-10-07T12:24:27.822425+00:00

missing or unspecified

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 08fa271d01e0583f570c97dd0d260073caf8f48877fa9f6d6eabc858b6e518d5

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

description
NA12892/NA12891 virtual tumor and matched normal; bounded primary-source AMP candidate.
Context-only references
Genome-wide somatic variant calling using localized colored de Bruijn graphs

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00
Retrieved: 2026-10-07T12:24:27.822425+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 08fa271d01e0583f570c97dd0d260073caf8f48877fa9f6d6eabc858b6e518d5

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

name
NA12892/NA12891 virtual tumor and matched normal
Context-only references
Genome-wide somatic variant calling using localized colored de Bruijn graphs

Original source ↗

No field-specific location recorded

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:24:27.822425+00:00
Retrieved: 2026-10-07T12:24:27.822425+00:00

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: 08fa271d01e0583f570c97dd0d260073caf8f48877fa9f6d6eabc858b6e518d5

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

View linked audit checks and correction history

Release 2026-10-07-1448159e6a81 · Record review: source checked

1 source records and release historyDownload this release
Technical metadata and extraction receipts

Stable ID: amp-oncology-rna-20261007-dataset-lancet-virtual-tumor

areas
dna-genomes
accession
Not reported
assay
Illumina HiSeq X PCR-free WGS, 80× virtual tumor and 40× normal
missing metadata
None recorded
population
31,592 spiked SNVs; 4,945 spiked indels; NA12892 and NA12891 HapMap samples
split
constructed evaluation; no training/test split extracted
version
Not reported
Related records

Suggest a correction